Thus, unlike other U5 proteins associated with cancer, the key role of DDX23 upregulation in glioma progression does not appear to stem from specific alterations in pre-mRNA splicing, but rather through additional functions of the protein, in this case microRNA processing. This evidence concerns the gene DDX23 and central nervous system cancer.